This inventor holds 4 USPTO granted patents. Top assignees: Richter Gedeon Vegyeszeti Gyar Rt, Egyt Gyogyszervegyeszeti Gyar. Active years: 1981-1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1981-1984
Title: Jozsef Szekely: Innovator in Pharmaceutical Chemistry
Introduction
Jozsef Szekely is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 4 patents to his name, Szekely's work has the potential to impact various medical treatments.
Latest Patents
Among his latest patents, Szekely has developed pentapeptides and processes for their preparation. Additionally, he has created analgesic compounds characterized by the formula (I): 3,4-Dihydro-5H-2,3-benzodiazepine derivatives. This invention relates to new 3,4-dihydro-5H-2,3-benzodiazepine derivatives of general formula (I) and pharmaceutically acceptable acid addition salts thereof. The compounds feature a phenyl group that may carry one or two substituents selected from halogen, hydroxy, C1-4 alkoxy, and benzyloxy, as well as furyl or thienyl groups.
Career Highlights
Szekely has worked with prominent companies in the pharmaceutical industry, including Richter Gedeon Vegyeszeti Gyar Rt and Egyt Gyogyszervegyeszeti Gyar. His experience in these organizations has allowed him to refine his expertise and contribute to innovative drug development.
Collaborations
Throughout his career, Szekely has collaborated with esteemed colleagues such as Sandor Bajusz and Andras Ronai. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Jozsef Szekely's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for new therapeutic solutions in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile